2023
DOI: 10.1016/j.ajhg.2022.11.012
|View full text |Cite
|
Sign up to set email alerts
|

Genome-wide analysis of copy-number variation in humans with cleft lip and/or cleft palate identifies COBLL1, RIC1, and ARHGEF38 as clefting genes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 141 publications
0
3
0
Order By: Relevance
“…Another limitation of this study is that Copy Number Variants (CNVs) were not included in the analysis. Although it is unlikely that, with the present small sample size, we could identify a CNV contribution, it has been recently suggested [51] that their role in orofacial clefts has been relatively overlooked.…”
mentioning
confidence: 66%
“…Another limitation of this study is that Copy Number Variants (CNVs) were not included in the analysis. Although it is unlikely that, with the present small sample size, we could identify a CNV contribution, it has been recently suggested [51] that their role in orofacial clefts has been relatively overlooked.…”
mentioning
confidence: 66%
“…Specific recommendations for diagnostic testing will continue to evolve as more data on the contribution of rare variants to both isolated and familial clefting accrues. Recent data supporting a role for rare copy number variants (Lansdon et al, 2023) and how to incorporate other genomic variants, including those in non-coding regions (Zieger et al, 2023), will require additional data and validation through analytic trials. But as some individuals with a positive family history will have questions about risks consideration should be given to sequencing studies to identify variants that might suggest higher than what epidemiologic recurrence risks alone would support.…”
Section: Discussionmentioning
confidence: 99%
“…Specific recommendations for diagnostic testing will continue to evolve as more data on the contribution of rare and common variants to both isolated and familial clefting accrues. Recent data supporting a role for rare copy number variants (Lansdon et al, 2023) and how to incorporate other genomic variants, including those in non‐coding regions (Zieger et al, 2023), will require additional data and validation through analytic trials. As individuals with a positive family history might have questions about risks, consideration should be given to sequencing studies to identify variants that might suggest higher recurrence risks than what epidemiologic studies alone would support.…”
Section: Discussionmentioning
confidence: 99%